Skip to main content

Tirzepatide: Efficacy and Safety Compared to Other Diabetes Medications

 Tirzepatide is a dual GIP and GLP-1 receptor agonist that has been approved by the FDA for the treatment of type 2 diabetes mellitus

2
. Here are some comparisons of tirzepatide's efficacy and safety to other diabetes medications:

Efficacy

  • In a global phase 3 trial, patients with obesity and type 2 diabetes or with overweight and type 2 diabetes lost an estimated 34.4 pounds (15.7%) of body weight with 10 mg and 15 mg of tirzepatide
    9
    .
  • The SURMOUNT-2 study found that individuals with type 2 diabetes and obesity lost an average of 15% of their body weight after 72 weeks of treatment with tirzepatide
    14
    .
  • Tirzepatide has been shown to be effective in improving blood sugar control in adults with type 2 diabetes. In clinical trials, all doses of tirzepatide demonstrated superiority in reducing A1C and body weight from baseline versus placebo or active comparators
    5
    .

Safety

  • Tirzepatide has a similar safety profile to other drugs in its class
    16
    .
  • Both tirzepatide and semaglutide have boxed warnings for the risk of thyroid C-cell tumors
    8
    .
  • There are still questions about the side effects of tirzepatide in people without type 2 diabetes
    8
    .

Comparison to Other Medications

  • An adjusted indirect treatment comparison found that tirzepatide 10 and 15 mg significantly reduced HbA1c and body weight versus semaglutide 2 mg
    1
    .
  • The Institute for Clinical and Economic Review (ICER) concluded that tirzepatide has "comparable or incremental net health benefits" compared to Ozempic and "comparable or inferior net health benefits" compared to Jardiance
    2
    .
  • A systematic review and meta-analysis found that tirzepatide exhibited superior characteristics of lowering HbA1c and fasting serum glucose compared to other diabetes medications
    15
    .
In summary, tirzepatide has been shown to be effective in reducing body weight and improving blood sugar control in adults with type 2 diabetes. It has a similar safety profile to other drugs in its class, but there are still questions about its side effects in people without type 2 diabetes. Compared to other diabetes medications, tirzepatide has been found to have comparable or superior efficacy in reducing HbA1c and body weight.


Citations:
[1] https://pubmed.ncbi.nlm.nih.gov/35589616/
[2] https://www.fiercepharma.com/pharma/lilly-s-tirzepatide-doesn-t-necessarily-top-diabetes-rivals-jardiance-and-ozempic-icer-says
[3] https://pubmed.ncbi.nlm.nih.gov/34672967/
[4] https://www.nejm.org/doi/full/10.1056/NEJMoa2107519
[5] https://www.drugs.com/compare/tirzepatide
[6] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10159347/
[7] https://www.drugdiscoverytrends.com/tirzepatide-vs-semaglutide-obesity-treatment-showdown/
[8] https://www.healthline.com/health/tirzepatide-vs-semaglutide
[9] https://pubmed.ncbi.nlm.nih.gov/36152639/
[10] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10231274/
[11] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987449/
[12] https://www.nejm.org/doi/full/10.1056/NEJMoa2206038
[13] https://nuvoyou.com/blog-1/f/tirzepatide-vs-semaglutide-for-weight-loss-what-you-must-know
[14] https://www.thelancet.com/journals/landia/article/PIIS2213-8587(22)00243-1/fulltext
[15] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9774036/
[16] https://investor.lilly.com/news-releases/news-release-details/lillys-tirzepatide-achieved-157-weight-loss-adults-obesity-or
[17] https://www.practiceupdate.com/content/2021-top-story-in-diabetes-tirzepatide-vs-semaglutide-in-patients-with-type-2-diabetes/128316
[18] https://www.acc.org/Latest-in-Cardiology/Clinical-Trials/2021/11/01/03/42/SURPASS-4
[19] https://dom-pubs.onlinelibrary.wiley.com/doi/10.1111/dom.14775
[20] https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0285197
[21] https://investor.lilly.com/news-releases/news-release-details/tirzepatide-results-published-lancet-show-superior-a1c-and-body
[22] https://www.frontiersin.org/articles/10.3389/fphar.2022.1016639/full
[23] https://investor.lilly.com/news-releases/news-release-details/lillys-tirzepatide-achieves-all-primary-and-key-secondary-study
[24] https://www.nature.com/articles/s41591-023-02344-1
[25] https://clinicaltrials.gov/ct2/show/NCT03730662
[26] https://diabetesjournals.org/clinical/article/41/2/258/148021/Efficacy-and-Safety-of-Tirzepatide-in-Adults-With
[27] https://www.fda.gov/news-events/press-announcements/fda-approves-novel-dual-targeted-treatment-type-2-diabetes
Labels:

Comments

Post a Comment

Please keep discussions respectful and on-topic

Popular posts from this blog

Flying Just Got a Lot More Expensive — and Tariffs Are Only the Beginning

 As trade tensions escalate between major economies, new tariff uncertainties are weighing heavily on airlines. The consequences will ripple far beyond boardrooms and airfields: travelers should expect higher ticket prices, fewer route options, and a possible reshaping of the global aviation landscape. Immediate Impacts: Airlines Navigate a New Set of Risks In the short term, airlines are grappling with a complex mix of operational challenges: First, the aircraft supply chain is under pressure. Trade disputes between the United States, the European Union, and China have complicated the procurement of new planes. Manufacturers like Boeing, Airbus, and China's state-backed COMAC are caught in the middle, creating delays and pricing uncertainty for carriers ( Reuters ). Fuel markets are similarly volatile. Airlines typically hedge fuel prices months in advance to avoid sudden cost spikes. However, unpredictable shifts in global oil prices—driven in part by trade instability—are u...
Post a Comment
Read more

What’s it like to grow up in Vienna, Austria? | Young and European

Key Themes and Insights: City Overview 🏙️ Vienna is often referred to as the 'City of Music' and has consistently been voted the world's most livable city. ✨ The city balances open-mindedness with rich traditions, offering impressive infrastructure and educational opportunities. Living Environment 🏡 Sebi enjoys living in the eighth district, Josefstadt, known for its proximity to the city center but high rental prices. 💰 The average rent in Vienna is €9.80 per square meter, making it relatively affordable compared to other European cities, although this district is an exception. Education System 📚 Sebi attends one of the oldest schools in Vienna, where he studies multiple languages and engages in higher education preparation. 🎓 The average age for Austrians to move out is 25.5 years, with many students like Sebi aspiring to continue their education at nearby universities, such as the University of Vienna. Transportation 🚉 Vienna has an excellent public transport syste...
Post a Comment
Read more

Could the Crown Slip? The Dollar's Grip in a Shifting World

 Alright, let's dive into the fascinating, and often overstated, question of whether the Euro could dethrone the mighty Dollar. Forget the daily market jitters; we're talking about the bedrock of global finance here. For decades, the US dollar has reigned supreme as the world's reserve currency. It's the currency most central banks hold in their reserves, the one used for pricing major commodities like oil, and the go-to for international trade. This dominance isn't just about bragging rights; it gives the US significant economic advantages, from lower borrowing costs to the ability to exert financial influence globally. But lately, whispers of change have grown louder. The idea that the dollar's grip might be loosening isn't some fringe conspiracy theory. Factors like the sheer scale of US debt, occasional bouts of political instability, and even the weaponization of financial sanctions have prompted some nations to explore alternatives. Think of it like a ...
Post a Comment
Read more